31 MADWorld AD

24 Pharmapack

23 PMPS

PME October 2026

40 PME AD

Comment

PMSociety

PME AD

27 - Communique

September 2026

Harnessing the power of social media for patient engagement; The next phase of oral GLP-1s; Incentivising new treatments for rare diseases


Explore how social media drives patient engagement, what’s next for oral GLP-1 drugs, and the incentives accelerating new rare disease treatments.

October 2026 - Pharmaceutical Market Europe

Strengthening engagement with HCPs; Regulatory challenges of cell and gene therapies; Why pharma needs humans at the helm of AI

How pharma can boost healthcare professional (HCP) engagement, navigate cell and gene therapy regulation, and keep human oversight in AI.

September 2026 - Pharmaceutical Market Europe

Celebrating the Communiqué Awards 2026!; Forging a connection with patients through creativity; GLP-1s and the consumer lifestyle shift

Discover highlights from the Communiqué Awards 2026, explore how creativity forges deeper patient connections, and learn how GLP-1s are driving a major consumer lifestyle shift in healthcare.

July/August 2026 - Pharmaceutical Market Europe

Steering GenAi into the pharma fast lane; ASCO 2026 – translating emerging science into better patient outcomes; Welcoming new PMEA chair

June 2026 - Pharmaceutical Market Europe

Making headway towards greater patient access; Men’s health – addressing the gap where lives are lost; The next frontier in clinical trials

May 2026 - Pharmaceutical Market Europe

Explore the April issue of PME, featuring the $150bn GLP-1 weight loss market and the race for oral obesity medications. This edition covers critical challenges in tuberculosis treatment adherence and the groundbreaking use of CAR-T cell therapies for lupus, an autoimmune condition disproportionately affecting women and ethnic minority groups. Stay ahead with the latest in pharmaceutical innovation and clinical breakthroughs.

Explore the April issue of PME: The $150bn GLP-1 weight loss market and the shift to oral meds, challenges in tuberculosis treatment adherence, and the potential of CAR-T cell therapies for lupus and autoimmune diseases. Read the latest pharma insights.

April 2026 - Pharmaceutical Market Europe

Inside this issue: Exploring the UK’s advanced therapy pipeline, closing the hormone gap in women's health, and tackling medicines access delays, plus features on building US media trust for European biotechs and the future of pharma manufacturing.

Exploring the UK’s advanced therapy pipeline, closing the hormone gap in women's health, and tackling medicines access delays, plus features on building US media trust for European biotechs and the future of pharma manufacturing.

March 2026 - Pharmaceutical Market Europe

Special feature on GenAI and its impact on pharma – A focus on Rare Disease Day on 28 February – Top Five Most Studied Diseases report

Expert articles on alzheimer's disease & dementia, clinical trial barriers, early diagnosis in Europe, plus ASH 2025 hematology conference coverage and oral health links to autoimmune disease.

February 2026 - Pharmaceutical Market Europe

January  2026 - Pharmaceutical Market Europe

Thermo Fisher Scientific’s Martin Danielson talks to PME; Celebrating the 2025 PMEAs; Redefining the prostate cancer landscape

December 2025 - Pharmaceutical Market Europe

ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains

November 2025 - Pharmaceutical Market Europe

Explore the 'Patient Metro' journey, the pillars of Alzheimer's blood testing, and how to de-risk clinical trials with platelet analysis for improved healthcare outcomes.

October 2025 - Pharmaceutical Market Europe

Pharmaceutical industry news, articles, jobs, reports, advice and services

Pharmaceutical Market Europe

PME – Pharmaceutical Market Europe is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

Pharmaceutical Market Europe

Pharmaceutical Market Europe (PME)

Categories

Social Footprints